FDA
-
-
-
-
-
-
-
Charles River creates advisory board for alternative testing methods
-
-
-
-
-
-
-
Charles River to initiate a review amid Elliott stake - Is a sale next?
-
-
-
-
-
-
-
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
-
-
-
-
-
-
-
Charles River Laboratories (CRL) Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
-
-
-
-
-
-
-
Charles River Laboratories Announces Third-Quarter 2023 Results
-
-
-
-
-
-
-
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
-
-
-
-
-
-
-
Charles River Launches HemaCare Donor App to Engage Diverse Donors and Source Cell Solutions for Critical Cell and Gene Therapy Research
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

